Learn more
Join Dexa

Challenges of Programmable Medicine

Jorge discusses the significant barriers to the widespread adoption of programmable medicines, including regulatory hurdles and the permanence of genetic edits. He highlights the complexities involved in accessing these therapies, which often require lengthy hospital stays and come with exorbitant costs. Despite their potential life-saving benefits, the high price tags associated with development and manufacturing are likely to limit accessibility for many patients.